10900 73rd Ave N Suite 150
Maple Grove, MN 55369 United States
|[Save to my library]|
Since being founded in July 2003, Lumen Biomedical's primary goal has been to create unique interventional devices that
outperform existing technologies and can be used in virtually any anatomical area. With this goal in mind, the company has
dedicated its efforts to developing and commercializing products for embolic protection and thrombus removal throughout the
body. The company believes that the FiberNet(R) Embolic Protection System, which received FDA clearance in November
2008, will establish a new standard and confidence in embolic protection.